# Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID

> **NCT03892707** · — · COMPLETED · sponsor: **Woerwag Pharma LLC** · enrollment: 500 (actual)

## Conditions studied

- Acute Non-specific Low Back Pain

## Interventions

- **DRUG:** Exposure of interest (within routine clinical practice):Vitamin B complexes Milgamma® and Milgamma® compositum

## Key facts

- **NCT ID:** NCT03892707
- **Lead sponsor:** Woerwag Pharma LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-15
- **Primary completion:** 2019-11-05
- **Final completion:** 2019-11-05
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03892707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03892707, "Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03892707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*